📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation Assay. (2021)

First Author: Bentley EM

Attributed to: One Health and accelerating Vaccines for Ebola and Lassa (OVEL) funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/tropicalmed6030155

PubMed Identifier: 34449756

Publication URI: http://europepmc.org/abstract/MED/34449756

Type: Journal Article/Review

Volume: 6

Parent Publication: Tropical medicine and infectious disease

Issue: 3

ISSN: 2414-6366